"There is no disputing the fact that American consumers pay 30 to 300 percent more for the same prescription drugs as our counterparts in Canada, Europe, and the rest of the world"
About this Quote
“There is no disputing the fact” is the politician’s version of a table slam: a preemptive move meant to close debate before it starts. Michael K. Simpson isn’t just describing a price gap; he’s trying to reframe prescription drugs from a market commodity into a moral and political scandal with a clean villain and a measurable harm. The number range “30 to 300 percent” is doing double duty. It’s broad enough to capture the messy reality of drug pricing (some drugs modestly higher, some wildly so) while still landing like an indictment. You don’t need to understand formularies or rebates to feel the insult.
The subtext is comparative shame. By invoking “Canada, Europe, and the rest of the world,” Simpson drafts an implicit jury of peers and suggests the U.S. has become the outlier in a way that’s not “exceptional” but exploitative. It’s also a subtle rebuttal to the standard industry defense that high U.S. prices bankroll innovation: if everyone else gets the same drugs cheaper, then the premium starts to look less like a noble subsidy and more like Americans being treated as captive payers.
Context matters because drug pricing is one of the rare issues where ideology blurs at the edges: conservatives hear “consumers” and “pay more,” liberals hear “unfairness” and “health care access.” The line is engineered to build a coalition by making the problem feel empirically settled and emotionally intolerable, setting the stage for policy action without yet naming the policy fight.
The subtext is comparative shame. By invoking “Canada, Europe, and the rest of the world,” Simpson drafts an implicit jury of peers and suggests the U.S. has become the outlier in a way that’s not “exceptional” but exploitative. It’s also a subtle rebuttal to the standard industry defense that high U.S. prices bankroll innovation: if everyone else gets the same drugs cheaper, then the premium starts to look less like a noble subsidy and more like Americans being treated as captive payers.
Context matters because drug pricing is one of the rare issues where ideology blurs at the edges: conservatives hear “consumers” and “pay more,” liberals hear “unfairness” and “health care access.” The line is engineered to build a coalition by making the problem feel empirically settled and emotionally intolerable, setting the stage for policy action without yet naming the policy fight.
Quote Details
| Topic | Health |
|---|
More Quotes by Michael
Add to List
